Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Genetic Diseases, Inborn × romidepsin × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Pleural Effusion, Malignant 1 Neoplasms 1 Neoplasm Metastasis 1 Genetic Diseases, Inborn 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

romidepsin 1 montanide ISA 51 1 detox adjuvant 1 Specimen Handling 1 Interleukin-2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00020202 2024-03-04

FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Genetic Diseases, Inborn, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡